2021
Immunosenescence in Childhood Cancer Survivors and in Elderly: A Comparison and Implication for Risk Stratification
LÁZNIČKOVÁ, Petra, Kamila BENDÍČKOVÁ, Tomáš KEPÁK a Jan FRIČZákladní údaje
Originální název
Immunosenescence in Childhood Cancer Survivors and in Elderly: A Comparison and Implication for Risk Stratification
Autoři
LÁZNIČKOVÁ, Petra (203 Česká republika, domácí), Kamila BENDÍČKOVÁ (203 Česká republika), Tomáš KEPÁK (203 Česká republika, domácí) a Jan FRIČ (203 Česká republika, garant)
Vydání
Frontiers in Aging, LAUSANNE, FRONTIERS MEDIA SA, 2021, 1663-4365
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30204 Oncology
Stát vydavatele
Švýcarsko
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 5.702
Kód RIV
RIV/00216224:14110/21:00121956
Organizační jednotka
Lékařská fakulta
UT WoS
001090275600001
Klíčová slova anglicky
childhood cancer survivor; immunosenescence; low-grade inflammation; accelerated aging; late effects; patient stratification; elderly
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 20. 2. 2024 12:22, Mgr. Tereza Miškechová
Anotace
V originále
The population of childhood cancer survivors (CCS) has grown rapidly in recent decades. Although cured of their original malignancy, these individuals are at increased risk of serious late effects, including age-associated complications. An impaired immune system has been linked to the emergence of these conditions in the elderly and CCS, likely due to senescent immune cell phenotypes accompanied by low-grade inflammation, which in the elderly is known as “inflammaging.” Whether these observations in the elderly and CCS are underpinned by similar mechanisms is unclear. If so, existing knowledge on immunosenescent phenotypes and inflammaging might potentially serve to benefit CCS. We summarize recent findings on the immune changes in CCS and the elderly, and highlight the similarities and identify areas for future research. Improving our understanding of the underlying mechanisms and immunosenescent markers of accelerated immune aging might help us to identify individuals at increased risk of serious health complications.
Návaznosti
MUNI/A/1325/2020, interní kód MU |
|